Hjem
Harleen Grewals bilde

Harleen Grewal

Professor
  • E-postHarleen.Grewal@uib.no
  • Telefon+47 55 97 46 31+47 994 50 554
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2022). The changing spectrum of microbial aetiology of respiratory tract infections in hospitalized patients before and during the COVID-19 pandemic. BMC Infectious Diseases. 1-11.
  • Vis forfatter(e) (2022). Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield. Scientific Reports.
  • Vis forfatter(e) (2022). Improving Assignments for Therapeutic and Prophylactic Treatment Within TB Households. A Potential for Immuno-Diagnosis? Frontiers in Immunology. 11 sider.
  • Vis forfatter(e) (2022). Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR). Trials.
  • Vis forfatter(e) (2022). Host Transcriptional Signatures Predict Etiology in Community-Acquired Pneumonia: Potential Antibiotic Stewardship Tools. Biomarker Insights. 8 sider.
  • Vis forfatter(e) (2022). Comparison of rapid molecular testing methods for detecting respiratory viruses in emergency care: a prospective study. Infectious Diseases. 247-254.
  • Vis forfatter(e) (2021). The Magnitude of Interferon Gamma Release Assay Responses in Children with Household Tuberculosis Contact Is Associated with Tuberculosis Exposure and Disease Status. The Pediatric Infectious Disease Journal. 763-770.
  • Vis forfatter(e) (2021). Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERONTB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania. PLOS ONE. 11 sider.
  • Vis forfatter(e) (2021). Host blood RNA transcript and protein signatures for sputum-independent diagnostics of tuberculosis in adults. Frontiers in Immunology. 1-10.
  • Vis forfatter(e) (2021). A 2-Dose AERAS-402 Regimen Boosts CD8<sup>+</sup> Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients. Frontiers in Immunology. 1-15.
  • Vis forfatter(e) (2020). Typing and classification of non-tuberculous mycobacteria isolates [. F1000 Research. 1-32.
  • Vis forfatter(e) (2020). Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations. BMC Infectious Diseases. 1-11.
  • Vis forfatter(e) (2020). Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes. Communications Biology. 1-10.
  • Vis forfatter(e) (2018). Incidence of tuberculosis and the influence of surveillance strategy on tuberculosis case-finding and all-cause mortality: A cluster randomised trial in Indian neonates vaccinated with BCG. BMJ Open Respiratory Research. 1-9.
  • Vis forfatter(e) (2017). Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children. Scientific Reports. 1-9.
  • Vis forfatter(e) (2016). The effect of deworming on tests of tuberculosis infection in children with recent tuberculosis exposure a randomized controlled trial. The Pediatric Infectious Disease Journal. 622-627.
  • Vis forfatter(e) (2016). Incidence of tuberculosis among school-going adolescents in South India. BMC Public Health. 11 sider.
  • Vis forfatter(e) (2016). High prevalence of primary drug resistance in children with intrathoracic tuberculosis in India. Paediatrics and International Child Health. 214-218.
  • Vis forfatter(e) (2016). BLR1 and FCGR1A transcripts in peripheral blood associate with the extent of intrathoracic tuberculosis in children and predict treatment outcome. Scientific Reports. 1-11.
  • Vis forfatter(e) (2016). Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum. Scientific Reports.
  • Vis forfatter(e) (2016). Added Value of IP-10 as a Read-Out of Mycobacterium tuberculosis - Specific Immunity in Young Children. The Pediatric Infectious Disease Journal.
  • Vis forfatter(e) (2015). Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis. BMC Microbiology.
  • Vis forfatter(e) (2015). Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. American Journal of Respiratory and Critical Care Medicine. 820-830.
  • Vis forfatter(e) (2014). Vitamin D levels in Indian children with intrathoracic tuberculosis. Indian Journal of Medical Research (IJMR). 531-537.
  • Vis forfatter(e) (2014). The tuberculin skin test in school going adolescents in South India: associations of socio-demographic and clinical characteristics with TST positivity and non-response. BMC Infectious Diseases.
  • Vis forfatter(e) (2014). The frequencies of IFNγ+IL2+TNFα+ PPD-specific CD4+CD45RO+ T-cells correlate with the magnitude of the QuantiFERON® gold in-tube response in a prospective study of healthy Indian adolescents. PLOS ONE.
  • Vis forfatter(e) (2014). TB Trials Study Group: Concordant or discordant results by the tuberculin skin test and the quantiFERON-TB test in children reflect immune biomarker profiles. Genes and Immunity. 265-274.
  • Vis forfatter(e) (2014). Influence of age and nutritional status on the performance of the tuberculin skin test and QuantiFERON®-TB Gold In-Tube in young children evaluated for tuberculosis in southern India. The Pediatric Infectious Disease Journal. e260-e269.
  • Vis forfatter(e) (2014). Increased level of acute phase reactants in patients infected with modern mycobacterium tuberculosis genotypes in mwanza, tanzania. BMC Infectious Diseases.
  • Vis forfatter(e) (2014). Effect of non-tuberculous mycobacteria on host biomarkers potentially relevant for tuberculosis management. PLoS Neglected Tropical Diseases.
  • Vis forfatter(e) (2014). Effect of micronutrient supplementation on treatment outcomes in children with intrathoracic tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition. 1287-1297.
  • Vis forfatter(e) (2014). Effect of micronutrient deficiency on QuantiFERON-TB Gold In-Tube test and tuberculin skin test in diagnosis of childhood intrathoracic tuberculosis. European Journal of Clinical Nutrition. 38-42.
  • Vis forfatter(e) (2014). Concordant or discordant results by the tuberculin skin test and the quantiFERON-TB test in children reflect immune biomarker profiles. Genes and Immunity. 265-274.
  • Vis forfatter(e) (2013). Two-step tuberculin skin testing in school-going adolescents with initial 0-4 millimeter responses in a high tuberculosis prevalence setting in South India. PLOS ONE. 10 sider.
  • Vis forfatter(e) (2013). TB Trials Study Group; Two-step tuberculin skin testing in school-going adolescents with initial 0-4 millimeter responses in a high tuberculosis prevalence setting in South India. PLOS ONE. e71470.
  • Vis forfatter(e) (2013). Role of the QuantiFERON (R)-TB Gold In-Tube test in the diagnosis of intrathoracic childhood tuberculosis. The International Journal of Tuberculosis and Lung Disease. 1383-1388.
  • Vis forfatter(e) (2013). Identification of biomarkers for Mycobacterium tuberculosis infection and disease in BCG-vaccinated young children in Southern India. Genes and Immunity. 356-364.
  • Vis forfatter(e) (2013). Does Neutralization of Gastric Aspirates from Children with Suspected Intrathoracic Tuberculosis Affect Mycobacterial Yields on MGIT Culture? Journal of Clinical Microbiology. 1753-1756.
  • Vis forfatter(e) (2013). Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania. Tropical medicine & international health. 822-829.
  • Vis forfatter(e) (2013). Ambulatory gastric lavages provide better yields of mycobacterium tuberculosis than induced sputum in children with intrathoracic tuberculosis. The Pediatric Infectious Disease Journal. 1313-1317.
  • Vis forfatter(e) (2012). Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection. The International Journal of Tuberculosis and Lung Disease. 1033-1039.
  • Vis forfatter(e) (2012). The effect of energy-protein supplementation on weight, body composition and handgrip strength among pulmonary tuberculosis HIV-co-infected patients: randomised controlled trial in Mwanza, Tanzania. British Journal of Nutrition. 263-271.
  • Vis forfatter(e) (2012). Mycobacterium tuberculosis Mcel protein complex initiates rapid induction of transcription of genes involved in substrate trafficking. Genes and Immunity. 496-502.
  • Vis forfatter(e) (2012). Effect of Ascaris Lumbricoides specific IgE on tuberculin skin test responses in children in a high-burden setting: a cross-sectional community-based study. BMC Infectious Diseases. 8 sider.
  • Vis forfatter(e) (2012). CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection. BMC Infectious Diseases. 7 sider.
  • Vis forfatter(e) (2012). Baseline Predictors of Sputum Culture Conversion in Pulmonary Tuberculosis: Importance of Cavities, Smoking, Time to Detection and W-Beijing Genotype. PLOS ONE. 7 sider.
  • Vis forfatter(e) (2011). Weight, body composition and handgrip strength among pulmonary tuberculosis patients: a matched cross-sectional study in Mwanza, Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene. 140-147.
  • Vis forfatter(e) (2011). The effect of vitamin A and zinc supplementation on treatment outcomes in pulmonary tuberculosis: a randomized controlled trial. American Journal of Clinical Nutrition. 93-100.
  • Vis forfatter(e) (2011). Modulation of transcriptional and inflammatory responses in murine macrophages by the mycobacterium tuberculosis mammalian cell entry (Mce) 1 complex. PLOS ONE. 11 sider.
  • Vis forfatter(e) (2011). How participatory is parental consent in low literacy rural settings in low income countries? Lessons learned from a community based study of infants in South India. BMC Medical Ethics. 9 sider.
  • Vis forfatter(e) (2011). Environmental tobacco smoke exposure increases Mycobacterium tuberculosis infection risk in children. The International Journal of Tuberculosis and Lung Disease. 1490-1496.
  • Vis forfatter(e) (2011). Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-Infected patients in Mwanza, Tanzania. Journal of Nutrition. 685-691.
  • Vis forfatter(e) (2010). Determination of the susceptibility of Mycobacterium tuberculosis to pyrazinamide in liquid and solid media assessed by a colorimetric nitrate reductase assay. Journal of Antimicrobial Chemotherapy. 704-712.
  • Vis forfatter(e) (2010). BCG vaccination status may predict sputum conversion in patients with pulmonary tuberculosis: a new consideration for an old vaccine? Thorax. 1072-1076.
  • Vis forfatter(e) (2009). Short-Term Reproducibility of a Commercial Interferon Gamma Release Assay. Clinical and Vaccine Immunology. 1170-1175.
  • Vis forfatter(e) (2009). Predominance of mycobacterium tuberculosis EAI and Beijing lineages in Yangon, Myanmar. Journal of Clinical Microbiology. 335-344.
  • Vis forfatter(e) (2009). Isoniazid and rifampicin resistance-asTisociated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. Journal of Antimicrobial Chemotherapy. 694-701.
  • Vis forfatter(e) (2009). In-depth molecular characterization of Mycobacterium tuberculosis from New Delhi--predominance of drug resistant isolates of the 'modern' (TbD1) type. PLOS ONE.
  • Vis forfatter(e) (2009). High diversity of Mycobacterium tuberculosis genotypes in South Africa and preponderance of mixed infections among ST53 isolates. Journal of Clinical Microbiology. 1848-1856.
  • Vis forfatter(e) (2009). Direct detection of mycobacterial species in pulmonary specimens by two rapid amplification tests, the gen-probe amplified mycobacterium tuberculosis direct test and the genotype mycobacteria direct test. Journal of Clinical Microbiology. 3635-3639.
  • Vis forfatter(e) (2008). Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. Journal of Clinical Microbiology. 3459-3464.
  • Vis forfatter(e) (2008). Genomic Diversity among Beijing and non-Beijing Mycobacterium tuberculosis Isolates from Myanmar. PLOS ONE. e1973.
  • Vis forfatter(e) (2008). Effect of high dose oral zinc in mice with severe infection with Streptococcus pneumoniae. Scandinavian Journal of Infectious Diseases. 363-367.
  • Vis forfatter(e) (2006). Evaluation of the nitrate-based colorimetric method for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures. Journal of Antimicrobial Chemotherapy. 987-991.
  • Vis forfatter(e) (2005). Tuberculosis in contacts need not indicate disease transmission. Thorax. 136-137.
  • Vis forfatter(e) (2005). Drug-resistant tuberculosis in Yangon, Myanmar. Scandinavian Journal of Infectious Diseases. 846-851.
  • Vis forfatter(e) (2004). Identification and molecular characterization of the gene encoding coli surface antigen 20 of enterotoxigenic Escherichia coli. FEMS Microbiology Letters. 131-138.
  • Vis forfatter(e) (1998). Mucosal antibodies can be measured in air-dried samples of saliva and feces. JIM - Journal of Immunological Methods. 163-172.
  • Vis forfatter(e) (1998). Mucosal antibodies can be measured in air-dried samples of saliva and feces. JIM - Journal of Immunological Methods. 163-172.
  • Vis forfatter(e) (1997). Expression of colonization factor antigen I fimbriae by enterotoxigenic Escherichia coli; influence by growth conditions and a recombinant positive regulatory gene. APMIS - Journal of Pathologiy, Microbiology and Immunology. 247-254.
  • Vis forfatter(e) (1997). Expression of colonization factor antigen I by enterotoxigenic <I>Escherichia coli</I>; influence of growth conditions and a recombinant positive regulatory gene. APMIS - Journal of Pathologiy, Microbiology and Immunology. 247-254.
  • Vis forfatter(e) (1997). Detection and characterization of the coli surface antigen 6 of enterotoxigenic <I>Escherichia coli</I> by using monoclonal antibodies. Journal of Clinical Microbiology. 867-872.
  • Vis forfatter(e) (1997). Detection and characterisation of the coli surface antigen 6 of enterotoxigenic Escherichia coli by using monoclonal antibodies. Journal of Clinical Microbiology. 867-872.
  • Vis forfatter(e) (1997). A new putative colonization factor, CS19, of human enterotoxigenic Escherichia coli. Infection and Immunity. 507-513.
  • Vis forfatter(e) (1997). A new fimbrial putative colonization factor, CS19 in human enterotoxigenic <I>Escherichia coli</I>. Infection and Immunity. 507-13.
  • Vis forfatter(e) (1994). Genotypic and phenotypic identification of coli surface antigen 6-positive enterotoxigenic Escherichia coli. Journal of Clinical Microbiology. 1295-1301.
  • Vis forfatter(e) (1993). Induction of Colonization Factor Antigen I and Coli Surface Antigen 4 of enterotoxigenic Escherichia coli. Vaccine. 221-226.
  • Vis forfatter(e) (1992). Use of nonradioactive DNA Hybridization for the identification of enterotoxigenic Escherichia coli harboring genes for colonization factor antigen/1, coli surface antigen 4 and putative colonization factor 0166. Journal of Clinical Microbiology. 1823-1828.
  • Vis forfatter(e) (1992). Genetic relationship of putative colonization factor 0166 to colonization factor antigen I and coli surface antigen 4 of enterotoxigenic Escherichia coli. Infection and Immunity. 3799-3806.
  • Vis forfatter(e) (1992). Colonization factor antigen I, coli surface antigen 4 and putative colonization factor 0166 of enterotoxigenic Escherichia coli are genetically related. Vaccine. 289-289.
  • Vis forfatter(e) (1991). Presence of cfaD-homologous sequences and expression of coli surface antigen 4 on enterotoxigenic Escherichia coli; relevance for diagnostic procedures. Microbial Pathogenesis. 297-304.
Faglig foredrag
  • Vis forfatter(e) (2018). ADVANCES IN THE DIAGNOSIS AND TREATMENT OF TUBERCULOSIS IN  CHILDREN- a decade of collaboration.
  • Vis forfatter(e) (2016). Vaccines for TB.
  • Vis forfatter(e) (2016). The future for diagnostics for TB with a focus on children.
  • Vis forfatter(e) (2016). MPT64 Antigen test.
  • Vis forfatter(e) (2015). Biomarkers of TB disease and treatment response in children with intrathoracic TB in India.
Populærvitenskapelig foredrag
  • Vis forfatter(e) (1998). Molecular microbiological and immunological studies of childhood diarrhea in India and Guinea-Bissau - relevance for vaccine development.
Vitenskapelig foredrag
  • Vis forfatter(e) (2018). Biomarkers of TB disease and treatment response in children.
  • Vis forfatter(e) (2015). Biomarkers of TB disease and treatment response in Indian children,.
  • Vis forfatter(e) (2014). TB Vaccines; Presented at the AIIMS Conferenceon Childhood Tuberculosis, New Delhi, India 16th November 2014.
  • Vis forfatter(e) (2014). TB Trials:Development of a TB clinical trial site in Southern India; presented at the TBVI conference on: A new horizon for preventive vaccines against TB. Spain, 7-8 May 2014 .
  • Vis forfatter(e) (2014). Immune responses to TB in children;presented at theAll India Institute of Medical Science Conference on Childhood Tuberculosis, NewDelhi, India 15th November 2014.
  • Vis forfatter(e) (2010). Nutritional intervention and novel diagnostics to improve community-based control of tuberculosis.
  • Vis forfatter(e) (2010). Interferon gamma release assays for TB.
  • Vis forfatter(e) (2010). Frequency and clinical outcome of patients with mixed Mycobacterium tuberculosis infections.
  • Vis forfatter(e) (2010). DIAGNOSTIC UTILITY OF THE QUANTIFERON GOLD IN-TUBE ASSAY IN PAEDIATRIC INTRATHORACIC TB PATIENTS.
  • Vis forfatter(e) (2010). A comparison of the QuantiFERON Gold In-Tube assay with the tuberculin skin test in infants.
  • Vis forfatter(e) (2008). Childhood Tuberculosis and HIV: epidemiology and research priorities.
  • Vis forfatter(e) (2007). • Role of intestinal pathogens in necrotizing enterocolitis, International conference on Necrotizing enterocolitis, EUPSA (European Pediatric Surgeons Association).
  • Vis forfatter(e) (2007). Preparing for tuberculosis vaccine efficacy trials.
  • Vis forfatter(e) (2005). The Host-pathogen interaction in TB with a special focus on the infecting strain.
  • Vis forfatter(e) (2004). Levels of antibodies against enterotoxigenic Escherichia coli and Vibrio cholerae in young childrenin Bhanktapur, Nepal.
  • Vis forfatter(e) (2001). Applications of microarrays. Department of epidemiology and International health, University of Barcelona, Spain.
  • Vis forfatter(e) (2001). Applications of microarrays in microbiology. Norwegian Annual society of microbiology meeting, Ullevål hospital, Oslo, 10th October 2001.
  • Vis forfatter(e) (1998). Measurement of specific IgA in fecal extracts and in intestinal lavage fluid for monitoring of mucosal immune responses after rectal and gastric immunization.
  • Vis forfatter(e) (1998). Measurement of specific IgA in fecal extracts and in intestinal lavage fluid for monitoring of mucosal immune responses after rectal and gastric immunization.
  • Vis forfatter(e) (1997). The colonization factor antigen I like group of fimbrial proteins of human enterotoxigenic Escherichia coli.
  • Vis forfatter(e) (1997). The colonization factor antigen I like group of fimbrial proteins of human enterotoxigenic <I>Escherichia coli</I>.
  • Vis forfatter(e) (1997). Air-dried saliva and feces can be used for analyses of mucosal antibodies.
  • Vis forfatter(e) (1997). Air-dried saliva and feces can be used for analyses of mucosal antibodies.
Leder
  • Vis forfatter(e) (2008). Opportunistic pathogens in AIDS: trends, diagnosis and priorities. Expert Review of Anti-Infective Therapy. 163-166.
Leserinnlegg
  • Vis forfatter(e) (2013). BCG protects against tuberculosis irrespective of HIV status: a matched case-control study in Mwanza, Tanzania. Thorax. 288-289.
  • Vis forfatter(e) (2011). Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing-authors' response. Journal of Antimicrobial Chemotherapy. 687-687.
Fagbok
  • Vis forfatter(e) (2006). The Role of Nutrition in Tuberculosis. In: Practical Approach to Tuberculosis Management. Jaypee Brothers Medical Publishers,(P) Ltd., New Delhi, India .
Mastergradsoppgave
  • Vis forfatter(e) (2012). Diagnostic utility of the tuberculin skin test and QuantiFERON-TB Gold In-Tube assay in children with probable intra-thoracic tuberculosis in India.
  • Vis forfatter(e) (2012). Assessment of the utility of repeat tuberculin testing: a prospective study of adolescents in a high tuberculosis prevalence setting in South India.
  • Vis forfatter(e) (2011). Feasibility, utility and acceptability of gastric aspiration and induced sputum sampling in young children for the diagnosis of mycobacterial infections; study conducted as part of the development of a TB vaccine site in South India.
  • Vis forfatter(e) (2011). Comparison of Tuberculin Skin Test and QuantiFERON TB Gold In-tube Assay for the diagnosis of tuberculosis infection and disease in young children; study conducted as part of the development of a TB vaccine site in Southern India.
  • Vis forfatter(e) (2009). Predictors of sputum conversion among pulmonary tuberculosis patients in Mwanza, Tanzania.
  • Vis forfatter(e) (2005). Pyrazinamide resistance among multi-drug resistant M. tuberculosis isolates from South African pulmonary tuberculosis patients.
  • Vis forfatter(e) (2004). Drug resistant tuberculosis in Yangon, Myanmar.
  • Vis forfatter(e) (2004). Drug resistant tuberculosis in Yangon, Myanmar.
Populærvitenskapelig artikkel
  • Vis forfatter(e) (2016). Recent progress in host transcriptome profiling paves the way for a future point-of-care test for pediatric TB. Clinical Laboratory International.
Brev til redaktøren
  • Vis forfatter(e) (2017). Re: "It may be too early to try to prove the effect of deworming on tuberculin reactivity". The Pediatric Infectious Disease Journal. 241-242.
  • Vis forfatter(e) (2015). Authors' responses. Indian Journal of Medical Research (IJMR).
Doktorgradsavhandling
  • Vis forfatter(e) (2015). Biomarkers Mycobacterium tuberculosis infection and disease in children in Southern India.
  • Vis forfatter(e) (2010). Antibiotic drug susceptibility testing of Mycobacterium tuberculosis.
  • Vis forfatter(e) (2009). Genotypic charactrisation of Mycobacterium tuberculosis isolates from high TB-burden countries.
  • Vis forfatter(e) (2004). Colonisation Factors of Enterotoxigenic Escherichia coli; detection and characterisation.
  • Vis forfatter(e) (1995). Colonization factors of enterotoxigenic Escerichia coli: detection and expression (dr. med.). -.
Intervju
  • Vis forfatter(e) (2005). De-fusing the TB time-bomb.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) (2011). Immunology of Tubercolosis: Basic Aspects and Relevance for Immunodiagnostic Tests. 24 sider.
Sammendrag/abstract
  • Vis forfatter(e) (2012). Effect of Ascaris Lumbricoides specific IgE on tuberculin skin test responses in children. BMC Infectious Diseases.
Poster
  • Vis forfatter(e) (2015). Point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum.
  • Vis forfatter(e) (2015). Do Non-tuberculous Mycobacteria affect Host Biomarkers Potentially Relevant for Tuberculosis Management?
  • Vis forfatter(e) (2015). Approaching a diagnostic point-of-care test for pediatric tuberculosis through evaluation of immune biomarkers across the clinical disease spectrum.
  • Vis forfatter(e) (2010). Vitamin A and zinc supplementation and treatment outcome in pulmonary TB: a controlled trial.
  • Vis forfatter(e) (2010). Clinical, Microbiological and Micronutrient profiles of pediatric intrathoracic TB patients in Delhi, India,.
  • Vis forfatter(e) (2010). A comparison of two different size standards for the determination of MIRU‐VNTR copy numbers.
  • Vis forfatter(e) (2007). Testing pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates.
  • Vis forfatter(e) (2006). Identification of deletions in clinical Mycobacterium tuberculosis isolates using comparative genomic hybridisation.
  • Vis forfatter(e) (2006). Dynamics of global macrophage expression responses to in vitro infection with wild-type and a hypervirulent mce1-mutant of M. tuberculosis.
  • Vis forfatter(e) (2004). Reactivation and reinfection of Mycobacterium tuberculosis contribute to disease among immigrants.
  • Vis forfatter(e) (2004). Detection of common agents of bacterial meningitis with a low density DNA array.
  • Vis forfatter(e) (2002). Genotypic and phenotypic characterisation of Mycobacterium tuberculosis isolates from Yangon, Myanmar.
Errata
  • Vis forfatter(e) (2009). Predominance of Mycobacterium tuberculosis EAI and Beijing Lineages in Yangon, Myanmar. Journal of Clinical Microbiology. 1283-1283.
Briefs
  • Vis forfatter(e) (2014). Childhood TB:evidence generated at All India Institute of Medical Sciences, New Delhi, India over the last 5 years.

Se fullstendig oversikt over publikasjoner i CRIStin.

Forskergrupper